| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $294,736 ) |
| | 2024 | 2024 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CALLE 18 122 135, ED O CIDEIM | CALI | | | | COL | D43TW006589 | Integration of Translational and Implementation Research Training on Leishmaniasis and other Vector-borne and Emerging Infectious Diseases | 000 | 20 | NIH | 3/19/2024 | $294,736 |
| | 2024 | 2021 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CALLE 18 122 135, ED O CIDEIM | CALI | | | | COL | U19AI129910 | Optimizing Surveillance and Treatment for Control of Cutaneous Leishmaniasis | 000 | 5 | NIH | 4/29/2024 | $0 |
| | 2024 | 2020 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CALLE 18 122 135, ED O CIDEIM | CALI | | | | COL | G11AI152214 | Implementing strategies for Building Capacity in Research Administration at CIDEIM, and subsequent dissemination within Colombia and the Latin American region | 000 | 1 | NIH | 5/15/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $297,958 ) |
| | 2023 | 2023 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CALLE 18 122 135, ED O CIDEIM | CALI | | | | COL | D43TW006589 | Integration of Translational and Implementation Research Training on Leishmaniasis and other Vector-borne and Emerging Infectious Diseases | 000 | 19 | NIH | 3/28/2023 | $297,958 |
| | 2023 | 2021 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CALLE 18 122 135, ED O CIDEIM | CALI | | | | COL | U19AI129910 | Optimizing Surveillance and Treatment for Control of Cutaneous Leishmaniasis | 000 | 5 | NIH | 3/6/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $297,783 ) |
| | 2022 | 2022 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CALLE 18 122 135, ED O CIDEIM | CALI | VALLE | | | COL | D43TW006589 | Integration of Translational and Implementation Research Training on Leishmaniasis and other Vector-borne and Emerging Infectious Diseases | 000 | 18 | NIH | 4/7/2022 | $297,783 |
| | 2022 | 2021 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CALLE 18 122 135, ED O CIDEIM | CALI | | | | COL | U19AI129910 | Optimizing Surveillance and Treatment for Control of Cutaneous Leishmaniasis | 000 | 5 | NIH | 5/26/2022 | $0 |
| | 2022 | 2020 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CALLE 18 122 135, ED O CIDEIM | CALI | | | | COL | G11AI152214 | Implementing strategies for Building Capacity in Research Administration at CIDEIM, and subsequent dissemination within Colombia and the Latin American region | 000 | 1 | NIH | 9/12/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $943,436 ) |
| | 2021 | 2021 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | U19AI129910 | Optimizing Surveillance and Treatment for Control of Cutaneous Leishmaniasis | 001 | 5 | NIH | 3/29/2021 | $0 |
| | 2021 | 2021 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | D43TW006589 | Integration of Translational and Implementation Research Training on Leishmaniasis and other Vector-borne and Emerging Infectious Diseases | 000 | 17 | NIH | 4/18/2021 | $297,940 |
| | 2021 | 2021 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CALLE 18 122 135, ED O CIDEIM | CALI | VALLE | | | COL | D43TW006589 | Integration of Translational and Implementation Research Training on Leishmaniasis and other Vector-borne and Emerging Infectious Diseases | 003 | 17 | NIH | 7/28/2021 | $75,000 |
| | 2021 | 2021 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | U19AI129910 | Optimizing Surveillance and Treatment for Control of Cutaneous Leishmaniasis | 000 | 5 | NIH | 3/22/2021 | $539,134 |
| | 2021 | 2020 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CALLE 18 122 135, ED O CIDEIM | CALI | VALLE | | | COL | D43TW006589 | Integration of Translational and Implementation Research Training on Leishmaniasis and other Vector-borne and Emerging Infectious Diseases | 002 | 16 | NIH | 6/18/2021 | $31,362 |
| | 2021 | 2020 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CALLE 18 122 135, ED O CIDEIM | CALI | VALLE | | | COL | G11AI152214 | Implementing strategies for Building Capacity in Research Administration at CIDEIM, and subsequent dissemination within Colombia and the Latin American region | 000 | 1 | NIH | 9/9/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $960,193 ) |
| | 2020 | 2020 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | D43TW006589 | Integration of Translational and Implementation Research Training on Leishmaniasis and other Vector-borne and Emerging Infectious Diseases | 002 | 16 | NIH | 7/28/2020 | $299,534 |
| | 2020 | 2020 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | D43TW006589 | Integration of Translational and Implementation Research Training on Leishmaniasis and other Vector-borne and Emerging Infectious Diseases | 003 | 16 | NIH | 9/17/2020 | $0 |
| | 2020 | 2020 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | G11AI152214 | Implementing strategies for Building Capacity in Research Administration at CIDEIM, and subsequent dissemination within Colombia and the Latin American region | 000 | 1 | NIH | 2/14/2020 | $107,991 |
| | 2020 | 2020 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | U19AI129910 | Optimizing Surveillance and Treatment for Control of Cutaneous Leishmaniasis | 000 | 4 | NIH | 3/20/2020 | $552,668 |
|
| Issue Date FY: 2019 ( Subtotal = $559,430 ) |
| | 2019 | 2019 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | U19AI129910 | Optimizing Surveillance and Treatment for Control of Cutaneous Leishmaniasis | 001 | 3 | NIH | 3/20/2019 | $559,430 |
| | 2019 | 2018 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | U19AI129910 | Optimizing Surveillance and Treatment for Control of Cutaneous Leishmaniasis | 000 | 2 | NIH | 1/8/2019 | $0 |
| | 2019 | 2017 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | R01AI104823 | Macrophage drug transport and metabolism in the outcome of antileishmania therapy | 000 | 5 | NIH | 5/31/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $566,695 ) |
| | 2018 | 2018 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | U19AI129910 | Optimizing Surveillance and Treatment for Control of Cutaneous Leishmaniasis | 000 | 2 | NIH | 4/5/2018 | $566,695 |
| | 2018 | 2017 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | R01AI104823 | Macrophage drug transport and metabolism in the outcome of antileishmania therapy | 000 | 5 | NIH | 3/8/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $690,654 ) |
| | 2017 | 2017 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | U19AI129910 | Optimizing Surveillance and Treatment for Control of Cutaneous Leishmaniasis | 000 | 1 | NIH | 4/12/2017 | $556,314 |
| | 2017 | 2017 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | R01AI104823 | Macrophage drug transport and metabolism in the outcome of antileishmania therapy | 000 | 5 | NIH | 1/10/2017 | $134,340 |
| | 2017 | 2015 | CORPORACION CENTRO INTERNACIONAL DE ENTRENAMIENTO E INVESTIGACIONES MEDICAS | CARRERA 125 NO. 19-2225 | CALI | VALLE | | | COL | R03TW009172 | Mechanisms of Immune Evasion and Recognition in Human Syphilis | 000 | 3 | NIH | 2/2/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $134,699 ) |
| | 2016 | 2016 | CORPORACION CTR INTL DE ENTRENAMIENTO DE INVESTIGACION | CARRERA 125 NO. 19-225 | CALI, VALLE | | | | COL | R01AI104823 | Macrophage drug transport and metabolism in the outcome of antileishmania therapy | 000 | 4 | NIH | 12/21/2015 | $134,699 |
|
| Issue Date FY: 2015 ( Subtotal = $181,915 ) |
| | 2015 | 2015 | CORPORACION CTR INTL DE ENTRENAMIENTO DE INVESTIGACION | CARRERA 125 NO. 19-225 | CALI, VALLE | | | | COL | R01AI104823 | Macrophage drug transport and metabolism in the outcome of antileishmania therapy | 000 | 3 | NIH | 1/26/2015 | $134,828 |
| | 2015 | 2015 | CORPORACION CTR INTL DE ENTRENAMIENTO DE INVESTIGACION | CARRERA 125 NO. 19-225 | CALI, VALLE | | | | COL | R03TW009172 | Mechanisms of Immune Evasion and Recognition in Human Syphilis | 000 | 3 | NIH | 4/14/2015 | $47,087 |
|
| Issue Date FY: 2014 ( Subtotal = $181,964 ) |
| | 2014 | 2014 | CORPORACION CTR INTL DE ENTRENAMIENTO DE INVESTIGACION | CARRERA 125 NO. 19-225 | CALI, VALLE | | | | COL | R03TW009172 | Mechanisms of Immune Evasion and Recognition in Human Syphilis | 000 | 2 | NIH | 3/11/2014 | $47,087 |
| | 2014 | 2014 | CORPORACION CTR INTL DE ENTRENAMIENTO DE INVESTIGACION | CARRERA 125 NO. 19-225 | CALI, VALLE | | | | COL | R01AI104823 | Macrophage drug transport and metabolism in the outcome of antileishmania therapy | 000 | 2 | NIH | 3/7/2014 | $134,877 |
|
| Issue Date FY: 2013 ( Subtotal = $183,136 ) |
| | 2013 | 2013 | CORPORACION CTR INTL DE ENTRENAMIENTO DE INVESTIGACION | CARRERA 125 NO. 19-225 | CALI, VALLE | | | | COL | R03TW009172 | Mechanisms of Immune Evasion and Recognition in Human Syphilis | 000 | 1 | NIH | 2/26/2013 | $26,836 |
| | 2013 | 2013 | CORPORACION CTR INTL DE ENTRENAMIENTO DE INVESTIGACION | CARRERA 125 NO. 19-225 | CALI, VALLE | | | | COL | R01AI104823 | Macrophage drug transport and metabolism in the outcome of antileishmania therapy | 000 | 1 | NIH | 2/11/2013 | $121,348 |
| | 2013 | 2013 | CORPORACION CTR INTL DE ENTRENAMIENTO DE INVESTIGACION | CARRERA 125 NO. 19-225 | CALI, VALLE | | | | COL | R01AI104823 | Macrophage drug transport and metabolism in the outcome of antileishmania therapy | 004 | 1 | NIH | 6/28/2013 | $121,348 |
| | 2013 | 2013 | CORPORACION CTR INTL DE ENTRENAMIENTO DE INVESTIGACION | CARRERA 125 NO. 19-225 | CALI, VALLE | | | | COL | R01AI104823 | Macrophage drug transport and metabolism in the outcome of antileishmania therapy | 001 | 1 | NIH | 6/5/2013 | $13,484 |
| | 2013 | 2013 | CORPORACION CTR INTL DE ENTRENAMIENTO DE INVESTIGACION | CARRERA 125 NO. 19-225 | CALI, VALLE | | | | COL | R01AI104823 | Macrophage drug transport and metabolism in the outcome of antileishmania therapy | 002 | 1 | NIH | 6/25/2013 | -$134,832 |
| | 2013 | 2013 | CORPORACION CTR INTL DE ENTRENAMIENTO DE INVESTIGACION | CARRERA 125 NO. 19-225 | CALI, VALLE | | | | COL | R01AI104823 | Macrophage drug transport and metabolism in the outcome of antileishmania therapy | 003 | 1 | NIH | 6/28/2013 | $13,484 |
| | 2013 | 2013 | CORPORACION CTR INTL DE ENTRENAMIENTO DE INVESTIGACION | CARRERA 125 NO. 19-225 | CALI, VALLE | | | | COL | R03TW009172 | Mechanisms of Immune Evasion and Recognition in Human Syphilis | 001 | 1 | NIH | 5/13/2013 | $21,468 |
|
|
